Comparison of three lipid formulations for synthetic surfactant with a surfactant protein B analog

Experimental Lung Research

Volumn 31, Issue 6, 2005, Pages 563-579

  Walther, Frans J ^a,b   Hernández Juviel, José M ^a   Gordon, Larry M ^a   Waring, Alan J ^a,c   Stenger, Patrick ^d   Zasadzinski, Joseph A ^d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California   (United States)

Author keywords

Captive bubble surfactometry; Dimeric SP B1 25 peptide; Fourier transform infrared spectroscopy; Lung function; Rats

Indexed keywords

CALFACTANT; CHOLESTEROL; DIMER; DIOLEOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPID; PALMITIC ACID; PALMITOYLOLEOYLPHOSPHATIDYLETHANOLAMINE; PALMITOYLOLEOYLPHOSPHATIDYLGLYCEROL; PALMITOYLOLEOYLPHOSPHATIDYLSERINE; PHOSPHATIDYLGLYCEROL; SURFACTANT PROTEIN B; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIPID COMPOSITION; LUNG ALVEOLUS SURFACE TENSION; LUNG FUNCTION; LUNG LAVAGE; LUNG VOLUME; MALE; MOLECULAR WEIGHT; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; RESPIRATORY DISTRESS SYNDROME; TISSUE OXYGENATION; VISCOSITY;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL PRODUCTS; HUMANS; LIPIDS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 22044433549     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021490951531     Document Type: Article

References (35)

1. Veldhuizen R, Nag K. Orgeig S, Possmayer F: The role of lipids in pulmonary surfactant. Biochim Biophys Acta. 1998;1408:80-108.
2. Khan MC, Anderson GJ, Anyan WR, Hall SB: Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol. 1995;269:L567-L573.
3. Notter RH, Wang Z, Egan EA, Holm BA: Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids. 2002;114:21-34.
4. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR: A mutation in tlie surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest. 1994;93:1860-1863.
5. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA: Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA. 1995;92:7794-7798.
6. Brown DR, Bloom BT, Cohen M, Myers MM, Egan EA, Kattwinkel J, Delmore P, Hall RT, Malloy MH, Holzman IR, Carlo WA, Pramanik AK, McCaffree MA, Weatherstone KB, Willett LD, Topper WH: Increased survival in low birth weight neonates given prophylactic surfactant. J Perinatol. 1998;18:431-435.
7. Walther FJ, Gordon LM, Zasadzinski JA, Sherman MA, Waring AJ: Surfactant protein B and C analogues. Mol Genet Metab. 2000;71:342-351.
8. Cochrane CG, Revak SD: Pulmonary surfactant protein B (SP-B): structure-function relationships. Science. 1991;254:566-568.
9. Lipp MM, Lee KYC, Takamoto DY, Zasadzinski JAN, Waring AJ: Coexistence of buckled and flat monolayers. Phys Rev Lett. 1998;81:1650-1653.
10. Bringezu F, Ding J, Brezensinski G, Waring AJ, Zasadzinski JA: Influence of pulmonary surfactant protein B on model lung surfactant monolayers. Langmuir. 2002;18:2319-2325.
11. Ding J, Doudevski I, Warriner HE, Alig T, Zasadzinski JAN, Waring AJ, Sherman MA: Nanostructure changes in lung surfactant monolayers induced by interactions between palmitoyloleoyl-phosphatidylglycerol and surfactant protein B. Langmuir. 2003;19:1539-1550.
12. 1-25 in neonatal and acute respiratory distress syndrome. Exp Lung Res. 2002;28:623-640.
13. Tanaka Y, Takei T, Aiba T, Masuda K, Kiuchi A, Fujiwara T: Development of synthetic lung surfactants. J Lipid Res. 1986;27:475-485.
14. Notter RH: Lung surfactants. Basic Science and Clinical Applications, vol 149. New York: Marcel Dekker; 2000.
15. Fields CG, Lloyd DH, Macdonald RL, Ottenson KM, Noble RL: HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 1991;4:95-101.
16. 1-25. Biophys J. 2000;79:377-384.
17. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
18. Baatz JE, Zou Y, Cox JT, Wang Z, Notter RH: High-yield purification of lung surfactant proteins sp-b and sp-c and the effects on surface activity. Protein Expr Purif. 2001;23:180-190.
19. Goormaghitgh E, Cabiaux V, Ruysschaert J.-M: Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem. 1990;193:409-420.
20. Schurch S, Bachofen H, Goerke J, Green F: Surface properties of rat pulmonary surfactant studied with the captive bubble method: absorption, hysteresis, stability. Biochim Biophys Acta. 1992;1103:127-136.
21. Schurch S, Bachofen H, Goerke J, Possmayer F: A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol. 1989;67:2389-2396.
22. Schoel WM, Schurch S, Goerke J: The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta. 1994;1200:281-290.
23. Malcolm JD, Elliot CD: Interfacial tension from height and diameter of a single profile drop or captive bubble. Can J Chem Eng. 1980;58:151-153.
24. 13C-enhanced Fourier transform infrared spectroscopy. J Peptide Res. 2000;55:330-347.
25. Gordon LM, Horvath S, Longo ML, Zasadzinski JA, Taeusch W, Faull K, Leung C, Waring AJ: Conformational and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci. 1996;5:1662-1675.
26. Byler DM, Susi H: Examination of the secondary structure of protein by deconvolved FTIR spectra. Biopolymers 1986;25:469-487.
27. Surewicz WK, Manisch HH: New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochim Biophys Acta. 1988;952:115-130.
28. Goormaghligh E, Raussens V, Ruysschaerl J.-M: Attenuated toial reflection infrared spectroscopy of proleins and lipids in biological membranes. Biochim Biophys Acta. 1999;1422:105-185.
29. King DM, Wang Z, Palmer HJ, Holm BA, Nouer RH: Bulk shear viscosities of endogenous and exogenous lung surfactants. Am J Physiol. 2002;282:L277-L284.
30. Bernhard W, Hoffmann S, Dombrowsky H, Rau GA, Kamlage A, Kappler M, Haitsma JJ, Freihorst J, von der Hardt H, Poets CF: Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol. 2001;25:725-731.
31. Postle AD, Heeley EL, Wilton DC: A comparison of the molecular species compositions of mammalian, lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol. 2001;129:65-73.
32. Whitsett JA, Nogee LM, Weaver TW, Horowitz AD: Human surfactant protein B: structure, function, regulation, and genetic disease. Physiol Rev. 1995;75:749-757.
33. Takamoto DY, Lipp MM, von Nahmen A, Lee KYC, Waring AJ, Zasadzinski JA: Interaction of lung surfactant proteins with anionic phospholipids. Biophys J. 2001;81:153-169.
34. 31P NMR spectroscopy. Chem Phys Lipids. 2001;112:67-79.
35. Bruni J, Taeusch HW, Waring AJ: Surfactant protein B: Lipid interactions of synthetic peptides representing the amino-terminal amphipathic domains. Proc Natl Acad Sci USA. 1991;88: 7451-7455.